Comments

Regeneron Pharmaceuticals

Q: What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

REGNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$672.98

-10.10-1.48%

At close: -

$672.98

0.000.00%

After Hours: Jan 31, 4:00 PM EDT

Q4 2024 Earnings in 3 days from now on Tue Feb 4th, before the market open

Conference call scheduled in 3 days at 8:30 AM Click to view the webcast

Regeneron Pharmaceuticals (REGN) Forecast

News Earnings Regeneron Pharmaceuticals (REGN) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Overview Rating

Good

Technicals Analysis

0100

Financials Analysis

0100

Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Quotes, Forecast and News Summary

Regeneron Pharmaceuticals Stock (NASDAQ: REGN) stock price, news, charts, stock research, profile.

Open	$677.29
Close	$672.98
Volume / Avg.	943.99K / 880.38K
Day Range	$671.96 - $688.00
52 Wk Range	666.25 - 1.21K
Market Cap	$73.95B
P/E Ratio	16.90
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	-
Days to Cover	2.54

Recent News

Regeneron Pipeline Aims To Address $220 Billion Therapeutic Opportunities By 2030

Regeneron promotes EYLEA, Libtayo, and Dupixent at JPMorgan event while touting a pipeline that targets major disease areas.

Vandana Singh

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference

JP Morgan highlights mixed sentiment for U.S. large-cap biopharma stocks as advancements in obesity drugs and key product launches shape 2025 outlook.

Vandana Singh

2 Gene-Editing Stocks Positioned for a Strong Comeback in 2025

Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA approval for the first CRSPR-based gene therapy treatment for sickle cell anemia (SCA)

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$677.29
Close	$672.98
Volume / Avg.	943.99K / 880.38K
Day Range	$671.96 - $688.00
52 Wk Range	666.25 - 1.21K
Market Cap	$73.95B
P/E Ratio	16.90
Dividend Yield	-
Exchange	NASDAQ
RSI	38
Short Interest	-
Days to Cover	2.54

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Regeneron Pharmaceuticals (REGN) stock?

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ:REGN) through any online brokerage.

View our list of the best stock brokerages

Who are Regeneron Pharmaceuticals (REGN) competitors?

There are no as such competitors for Regeneron Pharmaceuticals.

What is the forecast, or price target, for Regeneron Pharmaceuticals (REGN) stock?

Regeneron Pharmaceuticals has a consensus price target of $987.90.

What is the current price for Regeneron Pharmaceuticals (REGN)?

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $672.98 last updated January 31, 2025 at 4:00 PM EST.

Does Regeneron Pharmaceuticals (REGN) pay a dividend?

There are no upcoming dividends for Regeneron Pharmaceuticals.

When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?

Regeneron Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 1, 2025.

Is Regeneron Pharmaceuticals (REGN) going to split?

There is no upcoming split for Regeneron Pharmaceuticals.

What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.